Healthy Choice Wellness Corp. (HCWC)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-09-29. ClinicalTrials.gov
Dilution Risk
MEDIUM DILUTION RISKDilution score: 48/100 (MEDIUM), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 0.33% of float, squeeze risk: LOW
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Host Digital Inc. Announces Pricing of Common Stock Offering
- Host Digital Inc. Announces Common Stock Offering
- HCWC Nears Host Digital Merger as $1.25B AI Lease Adds Momentum
- Global Data Center Market Projected to Reach $517 Billion By 2030
- HCWC Announces Host Digital Secures $1.25 Billion, 15-Year AI Data Center Lease
- Healthy Choice Wellness Corp. Announces 1-for-35 Reverse Stock Split
- Zacks Initiates Coverage of HCWC With Neutral Recommendation
- HEALTHY CHOICE WELLNESS CORP.’S STOCKHOLDERS APPROVE ALL PROPOSALS IN CONNECTION WITH MERGER WITH HOST DIGITAL
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Negative affect influences the computations underlying food choice in bulimia nervosa. — Elife 2026 Oct 1 PMID 42821313
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Healthy Choice Wellness Corp..
Full HCWC Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.